BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26686999)

  • 1. Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
    Jing M; Wang J; Zhu S; Ao F; Wang L; Han T; Yue X; Zhu Y; Ye L; Liu S
    Vaccine; 2016 Jan; 34(4):516-522. PubMed ID: 26686999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice.
    Zhang G; Li X; Liu L; Li J; Chen Q; Huang S; Li Y; Wan X
    Biochem Biophys Res Commun; 2018 Oct; 504(4):865-870. PubMed ID: 30219230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
    Cornelius C; Schöneweis K; Georgi F; Weber M; Niederberger V; Zieglmayer P; Niespodziana K; Trauner M; Hofer H; Urban S; Valenta R
    EBioMedicine; 2016 Sep; 11():58-67. PubMed ID: 27568223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
    Zhang Q; Zhong J; Huan L
    Microbiol Res; 2011 Feb; 166(2):111-20. PubMed ID: 20227266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.
    Akbar SM; Abe M; Masumoto T; Horiike N; Onji M
    J Hepatol; 1999 May; 30(5):755-64. PubMed ID: 10365798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
    J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses
    George R; Ma A; Motyka B; Shi YE; Liu Q; Griebel P
    Hum Vaccin Immunother; 2020 Apr; 16(4):779-792. PubMed ID: 31687875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice.
    Cai X; Zheng W; Pan S; Zhang S; Xie Y; Guo H; Wang G; Li Z; Luo M
    Antiviral Res; 2018 Jan; 149():48-57. PubMed ID: 29129705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H; Han Q; Zhao H; Xu D; Zhang J
    Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells.
    Guan H; Lan S; Wu J; Tang B; Xu Y
    Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Dobrica MO; Lazar C; Paruch L; van Eerde A; Clarke JL; Tucureanu C; Caras I; Ciulean S; Onu A; Tofan V; Branzan A; Urban S; Stavaru C; Branza-Nichita N
    Vaccine; 2018 Sep; 36(38):5789-5795. PubMed ID: 30082163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.